Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04855643 · ClinicalTrials.gov registry record · NA
Home-based tDCS for Apathy in Alzheimer's Disease
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04855643 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 3 participants.
The verdict
NCT04855643, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to assess feasibility, acceptability, and safety of providing tDCS to Alzheimer's disease and related dementias (ADRD) patients with apathy and to assess the efficacy of tDCS for ADRD-related symptoms, with a primary focus on apathy.
Interventions
- DEVICE home-based active tDCS
- DEVICE home-based sham tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-08-20 |
| Est. Completion | 2022-07-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04855643
The ClinicalTrials.gov registry entry for NCT04855643 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which home-based active tDCS is the first listed.
NCT04855643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04855643 about?
NCT04855643 is a clinical study titled "Home-based tDCS for Apathy in Alzheimer's Disease". The purpose of this study is to assess feasibility, acceptability, and safety of providing tDCS to Alzheimer's disease and related dementias (ADRD) patients with apathy and to assess the efficacy of tDCS for ADRD-related symptoms, with a primary focus on apathy.
What is the current status of trial NCT04855643?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2021-08-20. Estimated completion is 2022-07-10.
What interventions are being tested in trial NCT04855643?
The interventions under investigation include: home-based active tDCS (DEVICE), home-based sham tDCS (DEVICE).
Who is sponsoring clinical trial NCT04855643?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.